202 related articles for article (PubMed ID: 37659215)
1. Mesh and layered electrospun fiber architectures as vehicles for Lactobacillus acidophilus and Lactobacillus crispatus intended for vaginal delivery.
Minooei F; Kanukunta AR; Mahmoud MY; Gilbert NM; Lewis WG; Lewis AL; Frieboes HB; Steinbach-Rankins JM
Biomater Adv; 2023 Nov; 154():213614. PubMed ID: 37659215
[TBL] [Abstract][Full Text] [Related]
2. Lactobacillus crispatus-loaded electrospun fibers yield viable and metabolically active bacteria that kill Gardnerella in vitro.
Mahmoud MY; Wesley M; Kyser A; Lewis WG; Lewis AL; Steinbach-Rankins JM; Frieboes HB
Eur J Pharm Biopharm; 2023 Jun; 187():68-75. PubMed ID: 37086869
[TBL] [Abstract][Full Text] [Related]
3. Fabrication and characterization of bioprints with Lactobacillus crispatus for vaginal application.
Kyser AJ; Masigol M; Mahmoud MY; Ryan M; Lewis WG; Lewis AL; Frieboes HB; Steinbach-Rankins JM
J Control Release; 2023 May; 357():545-560. PubMed ID: 37076014
[TBL] [Abstract][Full Text] [Related]
4. Rapid-dissolving electrospun nanofibers for intra-vaginal antibiotic or probiotic delivery.
Minooei F; Gilbert NM; Zhang L; Sarah NeCamp M; Mahmoud MY; Kyser AJ; Tyo KM; Watson WH; Patwardhan R; Lewis WG; Frieboes HB; Lewis AL; Steinbach-Rankins JM
Eur J Pharm Biopharm; 2023 Sep; 190():81-93. PubMed ID: 37479065
[TBL] [Abstract][Full Text] [Related]
5. Exploring potential of vaginal Lactobacillus isolates from South African women for enhancing treatment for bacterial vaginosis.
Happel AU; Kullin B; Gamieldien H; Wentzel N; Zauchenberger CZ; Jaspan HB; Dabee S; Barnabas SL; Jaumdally SZ; Dietrich J; Gray G; Bekker LG; Froissart R; Passmore JS
PLoS Pathog; 2020 Jun; 16(6):e1008559. PubMed ID: 32497109
[TBL] [Abstract][Full Text] [Related]
6. Lactobacillus rhamnosus HN001 and Lactobacillus acidophilus La-14 Attenuate Gardnerella vaginalis-Infected Bacterial Vaginosis in Mice.
Jang SE; Jeong JJ; Choi SY; Kim H; Han MJ; Kim DH
Nutrients; 2017 May; 9(6):. PubMed ID: 28545241
[TBL] [Abstract][Full Text] [Related]
7. Log (
Deng T; Shang A; Zheng Y; Zhang L; Sun H; Wang W
Bioengineered; 2022 Feb; 13(2):2981-2991. PubMed ID: 35038957
[TBL] [Abstract][Full Text] [Related]
8. Characterisation and selection of a Lactobacillus species to re-colonise the vagina of women with recurrent bacterial vaginosis.
McLEAN NW; Rosenstein IJ
J Med Microbiol; 2000 Jun; 49(6):543-552. PubMed ID: 10847208
[TBL] [Abstract][Full Text] [Related]
9. Effects of bacterial vaginosis-associated bacteria and sexual intercourse on vaginal colonization with the probiotic Lactobacillus crispatus CTV-05.
Ngugi BM; Hemmerling A; Bukusi EA; Kikuvi G; Gikunju J; Shiboski S; Fredricks DN; Cohen CR
Sex Transm Dis; 2011 Nov; 38(11):1020-7. PubMed ID: 21992977
[TBL] [Abstract][Full Text] [Related]
10. Influence of Lactobacillus crispatus, Lactobacillus iners and Gardnerella vaginalis on bacterial vaginal composition in pregnant women.
Witkin SS; Moron AF; Linhares IM; Forney LJ
Arch Gynecol Obstet; 2021 Aug; 304(2):395-400. PubMed ID: 33521838
[TBL] [Abstract][Full Text] [Related]
11.
Huang X; Lin R; Mao B; Tang X; Zhao J; Zhang Q; Cui S
Biomolecules; 2024 Feb; 14(2):. PubMed ID: 38397477
[TBL] [Abstract][Full Text] [Related]
12. Probiotics for the treatment of women with bacterial vaginosis.
Falagas M; Betsi GI; Athanasiou S
Clin Microbiol Infect; 2007 Jul; 13(7):657-64. PubMed ID: 17633390
[TBL] [Abstract][Full Text] [Related]
13. Orally administrated
Qi F; Fan S; Fang C; Ge L; Lyu J; Huang Z; Zhao S; Zou Y; Huang L; Liu X; Liang Y; Zhang Y; Zhong Y; Zhang H; Xiao L; Zhang X
Front Immunol; 2023; 14():1125239. PubMed ID: 37575226
[TBL] [Abstract][Full Text] [Related]
14. Lactobacillus strains isolated from the vaginal microbiota of healthy women inhibit Prevotella bivia and Gardnerella vaginalis in coculture and cell culture.
Atassi F; Brassart D; Grob P; Graf F; Servin AL
FEMS Immunol Med Microbiol; 2006 Dec; 48(3):424-32. PubMed ID: 17059467
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobial and inflammatory properties of South African clinical Lactobacillus isolates and vaginal probiotics.
Chetwin E; Manhanzva MT; Abrahams AG; Froissart R; Gamieldien H; Jaspan H; Jaumdally SZ; Barnabas SL; Dabee S; Happel AU; Bowers D; Davids L; Passmore JS; Masson L
Sci Rep; 2019 Feb; 9(1):1917. PubMed ID: 30760770
[TBL] [Abstract][Full Text] [Related]
16. Lactobacillus crispatus represses vaginolysin expression by BV associated Gardnerella vaginalis and reduces cell cytotoxicity.
Castro J; Martins AP; Rodrigues ME; Cerca N
Anaerobe; 2018 Apr; 50():60-63. PubMed ID: 29427630
[TBL] [Abstract][Full Text] [Related]
17. Gardnerella vaginalis alters cervicovaginal epithelial cell function through microbe-specific immune responses.
Anton L; Ferguson B; Friedman ES; Gerson KD; Brown AG; Elovitz MA
Microbiome; 2022 Aug; 10(1):119. PubMed ID: 35922830
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of vaginally administered lyophilized Lactobacillus crispatus IP 174178 in the prevention of bacterial vaginosis recurrence.
Bohbot JM; Daraï E; Bretelle F; Brami G; Daniel C; Cardot JM
J Gynecol Obstet Hum Reprod; 2018 Feb; 47(2):81-86. PubMed ID: 29196153
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of the two microorganisms Lactobacillus fermentum LF15 and Lactobacillus plantarum LP01, formulated in slow-release vaginal tablets, in women affected by bacterial vaginosis: a pilot study.
Vicariotto F; Mogna L; Del Piano M
J Clin Gastroenterol; 2014; 48 Suppl 1():S106-12. PubMed ID: 25291116
[TBL] [Abstract][Full Text] [Related]
20. Glycogen availability and pH variation in a medium simulating vaginal fluid influence the growth of vaginal Lactobacillus species and Gardnerella vaginalis.
Navarro S; Abla H; Delgado B; Colmer-Hamood JA; Ventolini G; Hamood AN
BMC Microbiol; 2023 Jul; 23(1):186. PubMed ID: 37442975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
